WASHINGTON TRUST Co Reduces Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

WASHINGTON TRUST Co reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.9% during the 4th quarter, Holdings Channel reports. The fund owned 560 shares of the biotechnology company’s stock after selling 23 shares during the period. WASHINGTON TRUST Co’s holdings in Axon Enterprise were worth $333,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Geode Capital Management LLC boosted its holdings in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC boosted its holdings in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new stake in Axon Enterprise during the third quarter worth $200,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $683.41 on Friday. Axon Enterprise, Inc. has a 52 week low of $260.27 and a 52 week high of $698.67. The stock has a market capitalization of $52.11 billion, a price-to-earnings ratio of 176.59, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The firm has a 50-day simple moving average of $623.22 and a 200-day simple moving average of $507.71. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on AXON shares. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, JMP Securities increased their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $542.15.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.